Sinil Pharmaceutical Co., Ltd. (KOSDAQ: 012790)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,400.00
-100.00 (-1.54%)
Dec 20, 2024, 9:00 AM KST

Sinil Pharmaceutical Company Description

Sinil Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally.

It offers pharmaceutical products for various indications, such as pain reliever, anti-inflammatory, hyperlipidemia, skin disease, and folic acid deficiency; and general/specialty drugs, veterinary drugs, and OEM products for various diseases.

The company also provides cosmetics, including skin care products, etc.; health functional products comprising vitamin supplements; and quasi-drugs for yellow dust, bacteria blocking, etc. In addition, it is involved in the real estate rental services.

The company was founded in 1971 and is headquartered in Chungju-si, South Korea.

Sinil Pharmaceutical Co., Ltd.
Country South Korea
Founded 1971
Industry Pharmaceutical Preparations
Employees 287
CEO Mi-Keun Jung

Contact Details

Address:
28, Boksanggol-gil
Chungju-si
South Korea
Phone 82 4 3722 3300
Website sinilpharm.com

Stock Details

Ticker Symbol 012790
Exchange KOSDAQ
Fiscal Year January - December
Reporting Currency KRW
SIC Code 2834

Key Executives

Name Position
Mi-Keun Jung Chief Executive Officer